https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-18 / Vaccine 2006 Feb;24(7):887-96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-18 / Vaccine 2006 Feb;24(7):887-962006-01-18 00:00:002019-02-15 08:37:42Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-01-01 / J. Gen. Virol. 2006 Jan;87(Pt 1):1-102006-01-01 00:00:002019-02-15 08:37:43Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-01 / Clin. Exp. Immunol. 2005 Nov;142(2):362-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-01 / Clin. Exp. Immunol. 2005 Nov;142(2):362-92005-11-01 00:00:002019-02-15 08:37:44Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Clin. Gastroenterol. Hepatol. 2005 Oct;3(10 Suppl 2):S78-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Clin. Gastroenterol. Hepatol. 2005 Oct;3(10 Suppl 2):S78-812005-10-01 00:00:002019-02-15 08:37:44Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-05-11 / Zhonghua Yi Xue Za Zhi 2005 May;85(17):1171-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-05-11 / Zhonghua Yi Xue Za Zhi 2005 May;85(17):1171-62005-05-11 00:00:002019-02-15 08:37:45[The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-03-28 / World J. Gastroenterol. 2005 Mar;11(12):1806-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-03-28 / World J. Gastroenterol. 2005 Mar;11(12):1806-82005-03-28 00:00:002019-02-15 08:37:47Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-28 / World J. Gastroenterol. 2005 Jan;11(4):557-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-28 / World J. Gastroenterol. 2005 Jan;11(4):557-602005-01-28 00:00:002019-02-15 08:37:48Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-18 / Blood 2005 May;105(9):3605-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-18 / Blood 2005 May;105(9):3605-142005-01-18 00:00:002019-02-15 08:37:46Uptake and presentation of hepatitis C virus-like particles by human dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / Int. J. Mol. Med. 2004 Aug;14(2):295-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / Int. J. Mol. Med. 2004 Aug;14(2):295-92004-08-01 00:00:002019-02-15 08:37:49Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / J. Clin. Virol. 2004 Aug;30(4):283-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / J. Clin. Virol. 2004 Aug;30(4):283-902004-08-01 00:00:002019-02-15 08:37:50Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus
